Drug Utilization Review (DUR) is designed to improve the quality of pharmaceutical care by ensuring that prescriptions are appropriate, medically necessary and unlikely to result in adverse medical outcomes. Medicaid’s DUR program includes prospective, online and retrospective review as well as use of standards developed by the National Council for Prescription Drug Programs (NCPDP). A board comprised of physicians and pharmacists provides guidance to Agency staff.

• Members – Drug Utilization Review Board - Updated 10/23/09

• Meeting Dates - 2009

• Agenda - October 28, 2009

• Minutes-July 22, 2009

• Minutes-April 22, 2009

• Minutes -January 28, 2009

• Minutes - October 22, 2008

• Minutes - July 23, 2008

• Minutes - April 23, 2008

• Minutes - January 23, 2008

• Minutes - October 24, 2007

• Minutes - July 25, 2007

• Minutes -  April 25, 2007

• Minutes - January 24, 2007

• Minutes - July 26, 2006

• Minutes - April 26,2006

• Minutes- January 25, 2006

• DUR Outcome Reject Codes

Note: Some documents are in PDF format. To view PDFs, please ensure you have the free Adobe Reader installed. If not, download the reader by clicking on the Adobe Reader icon.